Galmed Pharmaceuticals Statistics

Total Valuation

GLMD has a market cap or net worth of $4.60 million. The enterprise value is -$12.54 million.

Market Cap	4.60M
Enterprise Value	-12.54M

Important Dates

The next estimated earnings date is Friday, January 3, 2025, after market close.

Earnings Date	Jan 3, 2025
Ex-Dividend Date	n/a

Share Statistics

GLMD has 1.51 million shares outstanding. The number of shares has increased by 136.81% in one year.

Current Share Class	1.51M
Shares Outstanding	1.51M
Shares Change (YoY)	+136.81%
Shares Change (QoQ)	+58.13%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.49%
Float	1.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.25
P/TBV Ratio	0.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.03

Current Ratio	7.03
Quick Ratio	6.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.22% and return on invested capital (ROIC) is -24.96%.

Return on Equity (ROE)	-37.22%
Return on Assets (ROA)	-21.98%
Return on Capital (ROIC)	-24.96%
Revenue Per Employee	n/a
Profits Per Employee	-$790,500
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.76% in the last 52 weeks. The beta is 0.71, so GLMD's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-32.76%
50-Day Moving Average	3.25
200-Day Moving Average	4.07
Relative Strength Index (RSI)	49.92
Average Volume (20 Days)	47,428

Short Selling Information

Short Interest	22,773
Short Previous Month	17,424
Short % of Shares Out	3.08%
Short % of Float	n/a
Short Ratio (days to cover)	0.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.79M
Pretax Income	-6.36M
Net Income	-6.32M
EBITDA	-6.70M
EBIT	-6.79M
Earnings Per Share (EPS)	-$11.34

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	17.14M
Total Debt	n/a
Net Cash	17.14M
Net Cash Per Share	$11.37
Equity (Book Value)	18.44M
Book Value Per Share	12.23
Working Capital	15.17M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.81M
Capital Expenditures	n/a
Free Cash Flow	-4.81M
FCF Per Share	-$3.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-136.81%
Shareholder Yield	-136.81%
Earnings Yield	-137.59%
FCF Yield	-104.63%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 30, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Aug 30, 2024
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2